UPDATE: Peregrine Says 'New Data from Second Study...Shows Triple Combination of PS-Targeting Treatment, Anti-PD-1 and Anti-LAG3 Created Long-Term Immunity in Triple Negative Breast Cancer Model'
Paul Quintaro